Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Novartis Eyes 2019 for Launch of Investigational nAMD treatment February 21, 2018 9 Massachusetts Biotechs Facing Major FDA Decisions This Year March 2, 2017 Stanford University Clinical Geneticist Begins Presidency With The March 22, 2017
